Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-04

Clinical Trial Update: Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial updates the efficacy of alitretinoin for pustular psoriasis; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alitretinoin (alitretinoin)

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2017-04-04